QGEN:NYSE
Qiagen NV
$45.38
arrow_upward
+1.91%(+0.85) 1D
$45.38
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 9, 4:00:05 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QGEN...
Open
$44.99
High
$45.61
Low
$44.79
Mkt. cap
9.37B
Avg. vol.
2.08M
Volume
1.26M
Dividend
0.77%
Quarterly dividend
$0.09
Ex-dividend date
Jul 7, 2026
P/E ratio
23.35
52-wk high
$57.82
52-wk low
$32.53
EPS
$1.94
Beta
0.61
Shares outstanding
206.08M
No. of employees
6K
Open
$44.99
High
$45.61
Low
$44.79
Mkt. cap
9.37B
Avg. vol.
2.08M
Volume
1.26M
Dividend
0.77%
Quarterly dividend
$0.09
Ex-dividend date
Jul 7, 2026
P/E ratio
23.35
52-wk high
$57.82
52-wk low
$32.53
EPS
$1.94
Beta
0.61
Shares outstanding
206.08M
No. of employees
6K
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
Qiagen stock trades unchanged at EUR 40.51 as AI tools expand
TipRanks
·
2 days ago
BlackRock Reveals Substantial Voting Stake in Qiagen
TradingView
·
2 days ago
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG
Profile
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
About Qiagen NV
CEOThierry Bernard
Employees5.5K
FoundedNov 29, 1984
HeadquartersVenlo, Limburg, Netherlands
SectorHealth care
Websiteqiagen.com